Last reviewed · How we verify
NCT02776475
The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence
NA trial testing Sacral neuromodulation device turned off in Urinary Urge Incontinence in 18 participants. Terminated before completion.
27 May 2021
Quick facts
| Lead sponsor | TriHealth Inc. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 18 |
| Start date | 4 August 2016 |
| Primary completion | 27 May 2021 |
| Estimated completion | 27 May 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sacral neuromodulation device turned off
Conditions studied
- Urinary Urge Incontinence — all drugs for Urinary Urge Incontinence →
Sponsor
TriHealth Inc. — full company profile →
Who can join
Adults 18 to 85, female only, with Urinary Urge Incontinence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective one group cohort study seeks to investigate the effects of sacral neuromodulation on urinary urgency, frequency and urge incontinence are maintained after the simulator device is temporarily turned off for a period of four weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02776475
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Urge Incontinence
Currently open trials in the same condition.
- NCT07184307 — Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial · NA · recruiting
- NCT06217328 — RESTORE: An RCT to Evaluate the Efficacy of the Revi System · NA · active not recruiting
- NCT06161506 — Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer · Phase 2 · recruiting
- NCT04305743 — Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A · Phase 4 · recruiting
Other TriHealth Inc. trials
Trials by the same sponsor.
- NCT07017920 — Vitamin D and Hypertensive Disorders of Pregnancy · NA · not yet recruiting
- NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
- NCT06958003 — Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime · NA · enrolling by invitation
- NCT06957990 — Evaluation of Music Therapy for Pre-op/Intra-op During Hernia Surgery to Decrease the Need for Narcotics · NA · enrolling by invitation
- NCT06414083 — Histologic Comparison of Ablative Techniques for Endometriosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02776475 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TriHealth Inc.
- Last refreshed: 10 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02776475.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing